Atlas Trials

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00416650 · COMPLETED

Trial details

NCT number
NCT00416650
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2002-07-01
Primary completion
2007-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.